The expansion of the Company’s commercial relations and therefore its market presence began to develop dynamically in the middle of the twentieth century. As a result now it has a widely known brand name and well-established sales network in Hungary, the Central Eastern European and the CIS countries.
As the largest Hungarian pharmaceutical manufacturer, Richter has a marketing network that spreads over five continents; it has 29 representative offices and 27 sales and wholesale companies which supply active ingredients and finished products to more than a hundred countries throughout the world in addition to Hungary.
By the end of 2011 the Richter Group had set up its medical sales representative and marketing network in Western Europe in order to support the sale of the Company’s gynaecological products in the region. Acting under strategic cooperation contracts and long-term supply agreements, Richter supplies products to its partners in the United States as well.
Our Company’s primary objective is to be able to satisfy market demands in a flexible and cost-effective way, while devoting particular attention to reduce the fragmentation of its product range. As a consequence, the majority of the ten most widely sold preparations come from Richter’s three most important therapeutic groups. Sales of gynaecology, cardiovascular and central nervous system products account for 71% of the sales in the pharmaceutical manufacturing segment.
Approximately 90% of the Richter Group’s sales revenue comes from markets outside Hungary.